12:00 AM
Feb 22, 2000
 |  BC Week In Review  |  Company News  |  Deals

CytoGenix, PharmaGenix LLC deal

CYGX licensed its single stranded DNA intracellular expression vector, TroVec, to PharmaGenix, a joint...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >